使用常规收集健康数据研究中特应性皮炎疾病定义的系统综述
该系统综述检索PubMed、Embase和Web of Science,纳入59项使用常规收集电子健康数据并以特应性皮炎为主要结局的研究,评估患者识别方法及验证情况。仅2项研究报告了方法验证,患病率估计范围为0.18%至38.33%(中位数4.91%),识别方法差异可导致患病率高达三倍的变异。作者强调需清晰报告特应性皮炎患者识别方法以便结果解读与比较。
要点
- 59项研究中仅2项描述了患者识别方法的验证,无研究报告疾病严重程度。
- 患病率估计范围为0.18%至38.33%,中位数4.91%。
- 患者识别方法差异可引入高达三倍的患病率变异。
核心结论
- 该系统综述强调需要清晰报告在常规收集电子健康数据中识别特应性皮炎患者的方法,以便对结果进行有意义的解读和比较。
研究设计与样本
- 系统检索PubMed、Embase和Web of Science,纳入使用常规收集电子健康数据并以特应性皮炎为主要结局的研究,排除局限性特应性皮炎和其他类型皮炎的研究,方案在PROSPERO注册(CRD42016037968),共59项研究符合纳入标准。
主要发现
- 研究使用医学诊断编码(纳入和排除)、编码出现次数、与编码相关的提供者类型及处方数据来识别特应性皮炎患者。
- 仅2项研究描述了其方法的验证,无研究报告疾病严重程度。
- 患病率估计范围为0.18%至38.33%(中位数4.91%),识别方法差异可引入高达三倍的患病率变异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Routinely collected electronic health data obtained for administrative and clinical purposes are increasingly used to study atopic dermatitis (AD). Methods for identifying AD patients in routinely collected electronic health data differ, and it is unknown how this might affect study results. OBJECTIVES: To evaluate how patients with AD have been identified in studies using routinely collected electronic health data, to determine whether these methods were validated and to estimate how the method for identifying patients with AD affected variability in prevalence estimates. METHODS: We systematically searched PubMed, Embase and Web of Science for studies using routinely collected electronic health data that reported on AD as a primary outcome. Studies of localized AD and other types of dermatitis were excluded. The protocol for this review was registered in PROSPERO (CRD42016037968). RESULTS: In total, 59 studies met eligibility criteria. Medical diagnosis codes for inclusion and exclusion, number of occasions of a code, type of provider associated with a code and prescription data were used to identify patients with AD. Only two studies described validation of their methods and no study reported on disease severity. Prevalence estimates ranged from 0·18% to 38·33% (median 4·91%) and up to threefold variation in prevalence was introduced by differences in the method for identifying patients with AD. CONCLUSIONS: This systematic review highlights the need for clear reporting of methods for identifying patients with AD in routinely collected electronic health data to allow for meaningful interpretation and comparison of results.
引用
- Dizon MP, Yu AM, Singh RK, et al. Systematic review of atopic dermatitis disease definition in studies using routinely collected health data. Br J Dermatol. 2018. PMID: 29336013. doi:10.1111/bjd.16340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。